- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0037482

About Johnlee Pharmaceuticals Private Limited
Data last updated:
Johnlee Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46300MH2011PTC216610. Its GSTIN is 27AACCJ5804C1ZX (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Jsk Medicare Private Limited. It is led by directors Dilip Kishanlal Jain and Girish Kishanlal Jain.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No. 6 2nd Floor Om Shanti Co – Op. Hsg. Soc. 42/44 Babu Genu Road Kalbadevi, Mumbai, Maharashtra, India – 400002.
As per the financials filed for FY 2024, the company reported a revenue of ₹73.78 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹4.19 Cr (net margin 5.7%) and EBITDA of ₹6.97 Cr (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 20% over five years.
The company is associated with 1 brand: Johnlee Pharmaceuticals. As per MCA filings, the company has open charges of ₹6 Cr on record. Court records list 23 cases involving the company, including 8 filed by the company and 15 filed against it; 15 cases are pending.
Johnlee Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0037482). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website johnleeindia.com.
Company details
CIN history
Johnlee Pharmaceuticals has one previous CIN (Corporate Identification Number): U52399MH2011PTC216610. The current CIN is U46300MH2011PTC216610, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U46300MH2011PTC216610 | Current |
| U52399MH2011PTC216610 | Previous |
Recognitions & Rankings of Johnlee Pharmaceuticals
Contact details
Johnlee Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is johnleeindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No. 6 2nd Floor Om Shanti Co – Op. Hsg. Soc. 42/44 Babu Genu Road Kalbadevi, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Johnlee Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Johnlee Pharmaceuticals operates one associated brand: Johnlee Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and marketing of pharmaceutical formulations, including tablets, capsules, and injections in India. | johnleeindia.com |
Business activity
The main business activity of Johnlee Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Johnlee Pharmaceuticals Private Limited, buy the company report.
Financials of Johnlee Pharmaceuticals Private Limited
FY 2024 filings availableJohnlee Pharmaceuticals Private Limited reported revenue of ₹73.78 Cr (up 39% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 39% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹73.78 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.97 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Johnlee Pharmaceuticals Private Limited, buy the company report.
Board of directors of Johnlee Pharmaceuticals Private Limited
Johnlee Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dilip Kishanlal Jain Also directs: Yugrow Pharmacy LLP | Director | 25 Apr 2011 | 15 Years 6 Months | Current |
| Girish Kishanlal Jain Also directs: Yugrow Pharmacy LLP, Genericplus Pharmacy Private Limited | Director | 25 Apr 2011 | 15 Years 6 Months | Current |
Auditor
Johnlee Pharmaceuticals Private Limited is audited by JAIN & SANCHETI for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN & SANCHETI | FY 2024 | 113786W |
Shareholding
The shareholding of Johnlee Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Johnlee Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Aug 2018 | 100208232 | Others | ₹6 Cr | Open |
To see the full charge records of Johnlee Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Johnlee Pharmaceuticals Private Limited has 23 court cases on record: 8 filed by Johnlee Pharmaceuticals, 15 filed against it. 15 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 14 | 11 | 7 |
| District courts | 9 | 4 | 8 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| District court, Central, Delhi | Commercial suit | Filed by the company against Crossford Healthcare Private Limited and Ors and 1 other | Pending |
| District court, West, Delhi | Commercial suit | Filed by the company against Roussel Laboratories Private Limited and 2 others | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Vedriti Pharmacy Private Limited and 1 other | Pending |
To see the full case history of Johnlee Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Johnlee Pharmaceuticals Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 897 overdue payments to 51 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 51)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Oscar Remedies Pvt Ltd | |||
| United Bioceuticals Private Limited | |||
| Biodeal Pharmaceuticals Limited | |||
| Cian Healthcare Limited | |||
| Synokem Lifesciences Private Limited |
To see the full MSME payment records of Johnlee Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Johnlee Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCJ5804C1ZX | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Johnlee Pharmaceuticals Private Limited, buy the company report.
Recent activity
Johnlee Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Dilip Kishanlal Jain was appointed as Director on 25 Apr 2011.
Frequently asked questions
Johnlee Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2011 (15+ years old) and is registered under CIN U46300MH2011PTC216610.
Johnlee Pharmaceuticals has 2 current directors:
- Dilip Kishanlal Jain - Director
- Girish Kishanlal Jain - Director
The latest financial statements of Johnlee Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Johnlee Pharmaceuticals is 27AACCJ5804C1ZX, registered in Maharashtra.
The CIN (Corporate Identification Number) of Johnlee Pharmaceuticals is U46300MH2011PTC216610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Johnlee Pharmaceuticals has 23 court cases on record: 8 filed by the company and 15 filed against it. 15 are pending. Most are in the high courts.
Johnlee Pharmaceuticals was incorporated on 25 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Dilip Kishanlal Jain was appointed as Director on 25 Apr 2011. Girish Kishanlal Jain was appointed as Director on 25 Apr 2011.
Yes, Johnlee Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0037482).
Johnlee Pharmaceuticals has 13 MSME Form 1 returns on record between 2019 and 2024, listing 897 overdue payments to 51 micro and small suppliers. The latest return was filed on 09 May 2024.
Johnlee Pharmaceuticals can be reached through the website johnleeindia.com. Its registered office is in Mumbai, Maharashtra, India.